Tadalafil appears as an as-needed tablet, a daily tablet, a component of TEMPO, and a component of a nasal blend. The administration schedule is part of the research question.
2,918records matching the ingredient search
4connected formulations
7displayed publication records
How the research connects to the formula
The tablet listings distinguish 10 mg and 20 mg options from daily 2.5 mg and 5 mg options. TEMPO adds other ingredients and a sublingual format. The nasal product combines tadalafil with oxytocin and bremelanotide.
This map makes comparisons more precise: an ingredient-level paper can be connected to several products while keeping each product’s route and companions visible. Research on a daily oral regimen should retain that schedule when it is described.
The chart counts records mentioning the search terms in their title or abstract. It includes research beyond sexual health. Use the period controls to inspect the count.
2026: 106 indexed publications. 2026 includes publications dated through October 5. The earlier bars cover longer periods than the annual bars.
View the chart as a data table
Period
Publications
1900-1959
0
1960-1969
0
1970-1979
0
1980-1989
0
1990-1999
0
2000-2009
623
2010-2014
631
2015-2019
660
2020
150
2021
141
2022
161
2023
146
2024
140
2025
160
2026
106
Search query and data source
Source: Europe PMC’s PubMed-indexed records. Retrieved October 5, 2026. The index’s firstPublicationDate field supplies the dates and chart periods; it can normalize a month-only record to the first day of the month. Dates through October 5 are included. Counts can change as the index adds or corrects records.
TITLE_ABS:(tadalafil) AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]
The focused search returns 1,185 publications. It narrows the ingredient query to terms connected with its catalog use. Its displayed records remain a search sample, not a ranking of study quality.
View the focused query
TITLE_ABS:(tadalafil) AND TITLE_ABS:("erectile dysfunction") AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]
The timeline combines selected references with a sample from the ingredient search. Dates use the index’s firstPublicationDate field; the PubMed record may distinguish an earlier online date from the print date. Written study notes appear alongside the records that have them. Other entries show the indexed bibliography and link to the paper.
Journal Article
PDE5A variation is associated with tadalafil response in men with diabetes mellitus and erectile dysfunction: a prospective proof-of-concept pharmacogenetic study.
Hostnik B, Janež A, Goričar K, Blagus T, Dolžan V, Klen J. The journal of sexual medicine. PMID 42407102.
This record identifies a publication and its indexed publication types. The full paper contains the study methods, population, formulation and results.
Research data assembled by HealthRX.com from the displayed source records, October 5, 2026. The atlas contains a dated literature search and selected studies; it is not an exhaustive systematic review.